Monday, May 31, 2010

China Crescent Record $15 Million 1st Quarter Sales Boosts Company Toward $100 Million Annual Revenue Goal

DALLAS, TX--(Marketwire - 05/28/10) - China Crescent Enterprises, Inc. (OTC.BB:CCTR - News) today announced a Webcast presentation scheduled for Wednesday, June 2nd to present an updated 2010 outlook following the Company's record first quarter financial performance. China Crescent reported a more than 100% increase in first quarter revenue to nearly $15 million compared to the same period in 2009. Notably, net income increased more than 480% to approximately $657,000 versus the same period in 2009. The Company has announced a goal of reaching $100 million in 2010 annual revenue. The Wednesday presentation is scheduled to review the latest updates to the Company's 2010 outlook and a link to the Webcast will be posted to the corporate website, http://www.chinacrescent.com/, upon release.

Sign Up to Receive Regular China Crescent Investor Updates
China Crescent sends regular email updates to its opt-in, permission-based email database. Interested investors can easily, safely and quickly register to receive these communications directly on the corporate website homepage (http://www.chinacrescent.com/). Recipients can manage their own email contact profile and safely unsubscribe at any time.

About China Crescent Enterprises, Inc. (www.chinacrescent.com)
China Crescent is a systems integration service provider that markets technology outsourcing services in China including the sale and service of brand name technologies such as Microsoft, Oracle, Cisco, IBM, HP and Dell. Following a strategic acquisition last year, the Company expanded its business line to include original design manufacturing (ODM). China Crescent reported $45 million in profitable revenue in 2009 after reporting over $40 million in revenue for both 2007 and 2008 and has set a goal of reaching $100 million in revenue in 2010.

Headquartered in Dallas with operations in Shanghai, Shenzhen, Dalian and Beijing, China Crescent bridges the gap between global business cultures to assist clients worldwide realize the advantages of the high quality, low cost technology products and services available from China. China Crescent also assists clients in localizing products and services to realize the tremendous growth potential available by expanding into the Chinese Market.

"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause China Crescent's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.

Thursday, May 27, 2010

CCTR CFO Philip Rauch Reviews 1st Quarter 100% Revenue Growth to $15 Million and 480% Net Income Growth to $657K With Preview of Continued Growth

DALLAS, TX--(Marketwire - 05/27/10) - China Crescent Enterprises, Inc. (OTC.BB:CCTR - News) today announced a Webcast presentation conducted by CFO Philip Rauch reviewing the Company's first quarter performance highlights has been released at http://www.chinacrescent.com/. China Crescent reported a more than 100% increase in revenue to nearly $15 million compared to the same period in 2009. Notably, net income increased more than 480% to approximately $657,000 versus the same period in 2009. In the Webcast, Mr. Rauch also reviews the outlook for continued growth throughout 2010 and beyond. China Crescent is a systems integration service provider of brand name technologies and reported $45 million in profitable annual revenue in 2009. The Company's recent expansion into additional lines of business in China, including outsourcing services and original design manufacturing (ODM), has contributed to the growth. The Webcast titled 'China Crescent First Quarter 2010 Review Webcast (May 26, 2010)' is available under Recent Webcasts at http://r20.rs6.net/tn.jsp?t=mm4dbvdab.0.0.pcmgw6cab.0&p=http%3A%2F%2Fwww.chinacrescent.com%2F&id=preview or directly at http://www.chinacrescent.com/wcrq_20100526.htm.

Sign Up to Receive Regular China Crescent Investor Updates
China Crescent sends regular email updates to its opt-in, permission-based email database. Interested investors can easily, safely and quickly register to receive these communications directly on the corporate website homepage (http://www.chinacrescent.com/). Recipients can manage their own email contact profile and safely unsubscribe at any time.

About China Crescent Enterprises, Inc. (www.chinacrescent.com)
China Crescent is a systems integration service provider that markets technology outsourcing services in China including the sale and service of brand name technologies such as Microsoft, Oracle, Cisco, IBM, HP and Dell. Following a strategic acquisition last year, the Company expanded its business line to include original design manufacturing (ODM). China Crescent reported $45 million in profitable revenue in 2009 after reporting over $40 million in revenue for both 2007 and 2008 and has set a goal of reaching $100 million in revenue in 2010.

Headquartered in Dallas with operations in Shanghai, Shenzhen, Dalian and Beijing, China Crescent bridges the gap between global business cultures to assist clients worldwide realize the advantages of the high quality, low cost technology products and services available from China. China Crescent also assists clients in localizing products and services to realize the tremendous growth potential available by expanding into the Chinese Market.

"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause China Crescent's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.

Tuesday, May 25, 2010

TrustCash Announces Development of a Proprietary Mobile Device Manager to Support Over 5000 Mobile Devices

ATLANTA, GA--(Marketwire - 05/25/10) - TRUSTCASH LLC, a wholly owned subsidiary of TrustCash Holdings, Inc., ("TRUSTCASH") (Pinksheets:TCHH - News) today announces that is has completed the Alpha development phase of its proprietary JAVA Web Device Management Application.

An integral component to the development of a device/platform agnostic mobile payments product, this proprietary application enables the maintenance and updating of a complex mobile device database to ensure mobile device configuration is up-to-date.

This application can also extract mobile device configuration from the leading mobile industry body WURFL http://wurfl.sourceforge.net/.

WURFL is deployed at carriers and portals around the globe to maintain device standards for mobile applications and services.

The TrustCash Mobile Device Manager contains thousands of mobile devices times hundreds of capabilities. The matrix contains over 13,000 configuration possibilities and as new mobile devices, operating systems and features are released it will only grow larger. To make things more complex, each mobile device may have several subversions (often corresponding to different versions of the firmware). The TrustCash mobile Device Manager will position the TrustCash mobile payments product in a unique position as they enter the worldwide market for mobile payments which will grow to $633.4 billion by 2014, up from $68.7 billion in 2009, according to a new report by Generator Research.

Mr. Ajay Hans leading the mobile solutions product strategy confirms: "Our engineering team has created an automated maintenance protocol of the device database which is crucial as it determines how a page will be rendered on a mobile device. The ability to obtain an updated device configuration is critical to ensure a uniform user experience across all mobile devices, their numerous configurations and be platform agnostic. As the future of wireless continues to evolve our team has built the intelligence to handle all future and currently emerging devices to be the leader in mobile commerce."

TAKE OUR ONLINE SURVEY

Tell us where you want to use TrustCash at:

http://www.trustcash.com/signup_consumer1.php.

About TrustCash

The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.

The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Wednesday, May 19, 2010

TCHH Initiates Infrastructure Expansion Required to Support Mobile Commerce Development and Rollout

Worldwide Market for Mobile Payments Will Grow to $633.4 Billion by 2014

ATLANTA, GA--(Marketwire - 05/19/10) - TRUSTCASH HOLDINGS, INC. ("TRUSTCASH" or the "COMPANY") (Pinksheets:TCHH - News) today announces that with the assistance Alligato, Inc. the Company has doubled the size of its technology infrastructure.

Specifically, TrustCash has deployed its core technology infrastructure within a strategic development lab. The infrastructure deployment consists of enterprise level Hewlett Packard (HP) hardware and enterprise versions of JAVA technologies. The design of the platform is to be operating system agnostic currently set up within a Linux/Unix environment. All technologies have been acquired by the Company to implement the proprietary TrustCash end-to-end mobile commerce platform.

The Company believes that this achievement puts it on track for its entry into the burgeoning mobile payments market.

The Following article further confirms TrustCash's strategy:


•The worldwide market for mobile payments will grow to $633.4 billion by 2014, up from $68.7 billion in 2009, according to a new report by Generator Research. Meanwhile, mobile payment users will grow 600 percent to 490 million in 2014 from 81.3 million last year. Using your phone or your phone number to exchange money is convenient for everyone but especially the "underbanked." Whether it's payment dongle Square launching this week, Zong raising $15 million late last month on the strength of its virtual goods business on Facebook, or the fact that my dinner party companions last night settled the bill using Venmo, mobile payments are finally part of the present rather than the hazy projected future.
•http://gigaom.com/2010/05/13/mobile-payments-to-reach-633b-by-2014/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+OmMalik+%28GigaOM%29&utm_content=Google+International

TAKE OUR ONLINE SURVEY

Tell us where you want to use TrustCash at:

http://www.trustcash.com/signup_consumer1.php.

ABOUT TRUSTCASH

The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.

The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Juniper Group Announces New Contract with Industry Leader

BOCA RATON, Fla.--(BUSINESS WIRE)--Juniper Group (JUNP:OB) announced today that pursuant to a Master Service Agreement signed in early March with an industry leader that has designed over 34,000 towers and is licensed in all 50 states, its wholly-owned telecommunications subsidiary has been awarded a substantial contract for tower modifications in the Massachusetts market.

The requisite training for this customer, the country’s sixth largest telecommunications engineering and infrastructure provider, was focused on tower upgrades and modifications, and was successfully completed by late March.

Vlado P. Hreljanovic, President and CEO said, “This contract for over $134,000 represents what we hope will be only the first of many sites this year and the beginning of a long and successful relationship between our two companies. We have prepared extensively for this opportunity, and will put forth every effort to maintain and exceed customer expectations.”

Safe Harbor

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are based on current expectations, estimates and projections made by management. The Company intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, statements regarding the expected growth trend. All forward-looking statements in this press release are made as of the date of this press release, and Juniper assumes no obligation to update these forward-looking statements other than as required by law. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements and include the risk that our growth will not continue as anticipated and the factors discussed in the Business and Management’s Discussion and Analysis sections in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Copies of these filings are available at http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov%2F&esheet=6298310&lan=en_US&anchor=www.sec.gov&index=1&md5=2d7e8c68fbf4297b0558924001418d9b.

Monday, May 17, 2010

Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics

SANTA BARBARA, Calif., May 17 /PRNewswire-FirstCall/ -- Abviva, Inc. (Pink Sheets:ABVV.pk - News), a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, announced today that the Japanese Patent Office issued two patents on the core technology that may be used for therapeutic applications and in the Company's breast cancer risk assessment test, the Mammastatin Serum Assay (MSA). The patents are the most recent of 13 international and U.S. patents to issue to the University of Michigan for breast cancer diagnostic and therapeutic uses of Mammastatin.

"We are very pleased with this positive development," said Barrett Evans, CEO of Abviva. "Not only will these patent grants allow us to penetrate the Japanese market with proprietary technology, they further validate, along with previous patent grants covering 16 European countries, Canada, Australia, and the United States, the global patentability of the Mammastatin technology."

The MSA was initially developed at the University of Michigan Cancer Center and is licensed exclusively to Abviva by the University for scientific and commercial development as a blood test to assess women's health. In scientific correlation studies women who tested high with the MSA test showed to have lower risk of breast cancer than women who tested low. These findings align with results of the original research conducted at the University of Michigan Cancer Center that demonstrated Mammastatin was normally produced by breast epithelial cells in healthy women and was missing or reduced in transformed breast epithelial cells.

"This further solidifies the domestic and international intellectual property protection strategy we have implemented with the University of Michigan," continued Mr. Evans. "The issuance of this patent will be very important as we gain regulatory approval and market presence for the Mammastatin technology internationally. These newest patent grant notifications further expand our worldwide patent protection and marketability for MSA."

About Abviva

Abviva, Inc. is a biomedical company engaged in the innovation, development and commercialization of breast cancer related applications of Mammastatin, a growth inhibitory protein discovered at the University of Michigan Cancer Center that demonstrated anti-breast cancer properties. The discovery was developed into a simple breast cancer diagnostic blood test that demonstrated healthy women have high or normal levels of the protein and women with breast cancer have no detectable or very low levels of the protein. Abviva intends to commercialize the Mammastatin Serum Assay as a reference test through its wholly owned subsidiary laboratory under CLIA certification.

Statements in this press release that are not strictly historical facts are "forward-looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.

Sunday, May 16, 2010

Newron Sport Corporate & Shareholder Update

LAS VEGAS, NV--(Marketwire - 05/14/10) - Newron Sport (Pinksheets:NSPT - News) is pleased to provide a corporate and shareholder update.

Dear Shareholders:

The first quarter of 2010 has provided Newron Sport N.A. with an increasingly positive outlook for the remainder of the year. Newron has exceeded numerous test projections across the board, and remains at a steady growth. Customer satisfaction is at levels higher than anticipated.

There have been various changes that took place over the last few months, which have paved the way for impressive new retail listings and has opened the door to numerous options. These options include potential joint venture and licensing opportunities that are favorable to Newron Sport. The company has turned its attention to the refinement of administrative systems, issues of compliance, and the expansion of the company's sales division. Newron Sport has also made important and substantive progress for the 2010 year.

Newron will continue with the forward momentum as the sales year continues and will keep looking for opportunities that will maximize shareholder value. The Company is focused 100% on developing its technology and obtaining customers. Newron Sport has no intention on doing any kind of splits on the current stock. We do hope our continued positive momentum is reflected in our stock price sooner than later. Our team is determined to bring Newron to a position of leadership in the sporting good industry, and we will not rest until that goal has been achieved.

Newron appreciates the support and patience of its loyal shareholders and hopes that 2010 will be a very prosperous year for the company and its shareholders.

Sincerely,

The Newron Management Team.

About Newron Sport

Newron's patented tandem device is a unique product that focuses on both recreational use and enhancing sports performance by allowing the enjoyment of inline skating on hard and rough surfaces without the vibrations and loss of balance because of surface imperfections as the Newron skate system absorbs these imperfections and provides the inline skate user the feel of a smooth glide, stride and maneuverability of an ice skate, all while offering the user a safer and more efficient braking system than the conventional inline skates.

The Newron inline skates is intended both to help prevent injury and to improve athletic performance via its confidence enhancing attributes among inline skate sports participants. The Newron inline skate seeks to foster the enjoyment of sports by people of all ages.

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

TrustCash Closes Acquisition of 25% of Alligato, Inc.

ATLANTA, GA--(Marketwire - 05/14/10) - TrustCash Holdings, Inc. ("TrustCash") (Pinksheets:TCHH - News) today announces it has closed the acquisition of 25% of Alligato Inc.

The acquisition was structured as an exchange of restricted common stock.

TrustCash Management comments: "This brings the two teams closer and is a logical step forward. We are excited by the prospect of creating a company that can provide complex billing, taxation, mobile and payment solutions all under one roof."

Alligato markets its service under the http://www.celllongdistance.com/ brand.

Alligato™ delivers the most sophisticated, comprehensive voice 2.0 platform available. The technology infrastructure provides the first truly open access to carrier-grade telecom functionality with hardware, software and network capacity to lower the cost of cell phone long distance from the wireless network to the Public Switched Telephone Network (PSTN) as an on-demand, fully hosted and managed service in a CaaS (Communications as a Service) model.

The Alligato service enables large member based organizations, existing service providers, application providers and web communities, to provide cell phone long distance for their customers and members with greater quality and at significantly lower costs (up to 90% savings).

TAKE OUR ONLINE SURVEY

Tell us where you want to use TrustCash at:

http://www.trustcash.com/signup_consumer1.php.

About TrustCash

The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.

The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Juniper Group Rebuilding Continues; Company Closes in on $1 Million in Quarterly Revenues

BOCA RATON, Fla.--(BUSINESS WIRE)--Juniper Group (JUNP:OB) today reported nearly $1 million in revenue for the first quarter of 2010, as the company continues to see improved results from implementation of a new business model in its wireless infrastructure services subsidiaries. The company reported $991,000 for the quarter ended March 31, an increase of approximately 23% from the previous quarter.

Since mid-2009, Juniper Group’s management has focused on its wireless business. Vlado P. Hreljanovic, President and CEO said, “Our administrative, technical, and sales teams continue to do an exemplary job in expanding our business and generating new business opportunities. Our emphasis on customer satisfaction is key to our financial growth. We will do everything in our power to build on the positive trends which started in late 2009 and which we expect will continue throughout the remainder of 2010.”

Safe Harbor

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are based on current expectations, estimates and projections made by management. The Company intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, statements regarding the expected growth trend. All forward-looking statements in this press release are made as of the date of this press release, and Juniper assumes no obligation to update these forward-looking statements other than as required by law. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements and include the risk that our growth will not continue as anticipated and the factors discussed in the Business and Management’s Discussion and Analysis sections in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Copies of these filings are available at http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov%2F&esheet=6292396&lan=en_US&anchor=www.sec.gov&index=1&md5=f59c057f42db98d1e1a77352fa5161fc.

Thursday, May 13, 2010

PLBI/RegenoBody Announces Restructure of Convertible Preferred Shares

SOSUA BAY, Dominican Republic, May 13, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News) announced today that Armando Casciati has signed and authorized the filing of an amendment to the Articles of Incorporation of the Company whereby his Series B Preferred Convertible Stock rights are changed. The change will eliminate his right to convert his 19,600,000 preferred shares into 1,000 shares of common for each preferred and will essentially grant him a super voting share holding position which will be able to convert into 55% of the common stock when combined with his common holdings. As of the date of this release, the conversion right would not affect any shareholders since Mr. Casciati currently owns approximately 70% of the issued common shares currently outstanding.

In addressing this matter Mr. Casciati stated, "It was never my intent to have the Preferred Shares designated in the manner that they were issued. Former management had authorized and filed the designation as it was shown on our information statement. This new amendment and designation corrects the agreement that was made at the time of our being acquired by Proton Laboratories, Inc. and eliminates the huge overhang in the market that the prior designation created. The Amendment was filed last week and should be available for retrieval in the next 7 days."

About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A:

RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most potent cells in the world today. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic method. Their transplant physicians and stem cell laboratory scientists, in conjunction with RNL Bio, have been regarded as the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments are delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.

About RNL Bio Company LTD:

RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.



FORWARD-LOOKING STATEMENT:


This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.

Tuesday, May 11, 2010

PLBI/RegenoBody Announces Agreement for Equipment From RNL Bio Co Ltd.

SOSUA BAY, Dominican Republic, May 11, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News) announced today that following its success in attaining exclusive rights for RNL Bio Company Ltd's licenses, technology and equipment which allows PLBI's wholly owned subsidiary, RegenoBody, S.A. to treat anyone within the Caribbean, Central and/or South America, that the laboratory needed to perform the work is being designed by RNL Bio for shipment to the RegenoBody facility in the Dominican Republic. The laboratory will be designed according to the specifications required of RNL Bio in Korea so that it can duplicate the success of RNL Bio in regenerating human stem cells.

The initial concept of bringing what was once stereotyped as a controversial treatment to this hemisphere was based upon more than a year of research and the actual treatment and successful results of PLBI's President, Armando Casciati. After Mr. Casciati's treatment, he acquired the majority control of PLBI.pk, in an effort to accelerate the process of bringing stem cell technology to the Western Hemisphere.

Mr. Casciati stated, "Entrepreneurs typically look merely for profit opportunities. I am proud to have found such an incredible life opportunity which will help serve the public with some of the latest technological advances in medical history. I believe our alliance with RNL Bio Company will prove to be a life changing opportunity for our clients, as it has been for me."

RNL Bio Company LTD is considered a leader in stem cell technology with a wealth of treatments. After years of investment and research, RNL has developed technology ranging from cosmetic and arthritic needs to spinal cord injury and cancer treatments.

Korean FDA approved RNL's human clinical study to treat patients with spinal cord injury using 'RNL-Astrostem' that is based on fat derived adult stem cells.

In early 2009, RNL Bio publicly presented its three years' preclinical trial results showing a perfect safety profile and remarkable efficacy potential. RNL was approved by the Korean government to begin phase I human trial using these adult stem cells and we believe it is the world's first trial to treat spinal cord injury with adult stem cells derived from a patients' own fat tissue.

Since the Korean FDA approval, RNL Bio has progressively increased the utility of its RNL-Astrostem technology. RNL-Astrostem is administered by intravenous infusion so patients don't have to worry about any invasive and painful surgical procedure. Dr. Jeong Chan Ra, CEO of RNL Bio, said, "Our stem cell therapeutics involves no immune rejection because the stem cells are exactly the patient's own. Our adult stem cell has no tumorigenicity activity at all while embryonic stem cell faces high risk of it. We have developed the safest therapeutics to help devastated patients with incurable diseases."



About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A:


RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc. brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most potent cells in the world, today. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic method. Their transplant physicians and stem cell laboratory scientists, in conjunction with RNL Bio, have been regarded as the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments are delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.



About RNL Bio Company LTD:



RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.



FORWARD-LOOKING STATEMENT:



This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the Company undertakes no obligation to update such statements.

Newron Sport (NSPT) Completes Agreement With National Hockey Inline Association to Increase Newron Brand Exposure

LAS VEGAS, NV--(Marketwire - 05/11/10) - Newron Sport (Pinksheets:NSPT - News) is pleased to announce that it has completed negotiations with National Inline Hockey Association-Canada (NIHA-Canada). NIHA-Canada (http://www.niha.ca/) will allow Newron the ability to directly market and sell to all NIHA members and through its network of affiliations, which includes the International Ice Hockey Federation. The International Ice Hockey Federation's rules govern the hockey World Championships and the Olympics.

NIHA-Canada consists of a membership base of over 9,000 inline hockey players, as well as a National Men's Team Program that attends the IIHF Men's World Inline Championships on an annual basis. NIHA-Canada is recognized as the governing body for inline hockey by Hockey Canada, USA Hockey and the International Ice Hockey Federation.

Mr. Nathan Fleck, the Executive Director of NIHA-Canada, stated, "NIHA-Canada is very excited to partner with Newron Sports and be a part of the technological advances they are making with the standard roller hockey skate. By partnering with Newron Sports we hope to provide every roller hockey player in Canada with the opportunity to try the newest product on the market. Newron's technology will make it easier to transfer their ice hockey skills as well as assist the new players in getting accustomed to skating on wheels."

Mr. Fleck further commented, "NIHA-Canada is proud to be associated with a company like Newron Sports who are dedicated to growing the sport of roller hockey by providing the best possible equipment to players. NIHA-Canada is looking forward to providing opportunities to players across Canada to upgrade their skates to Newron technology."

Mr. Robert Ritondo, President of Newron Sport N.A., stated, "The opportunity that we have just been provided upon closing this deal with NIHA-Canada is tremendous. Not only will be able to supply over 9000 members but the agreement with NIHA-Canada will also expand Newron's brand recognition into international markets through Hockey Canada, USA Hockey and International Ice Hockey Federation.

"We would hopefully one day, like to work towards possibly being one of the IIHF Supplier Pool Members, which includes Bauer, Busch, Easton Sports, Graf, Fischer, Frontier, Rebellion, Reebok/CCM, Sherwood Inc, Tackla and Warrior, who have all made their equipment available to qualifying National Associations," continued Mr. Ritondo.

About Newron Sport

Newron's patented tandem device is a unique product that focuses on both recreational use and enhancing sports performance by allowing the enjoyment of inline skating on hard and rough surfaces without the vibrations and loss of balance because of surface imperfections as the Newron skate system absorbs these imperfections and provides the inline skate user the feel of a smooth glide, stride and maneuverability of an ice skate, all while offering the user a safer and more efficient braking system than the conventional inline skates.

The Newron inline skates is intended both to help prevent injury and to improve athletic performance via its confidence enhancing attributes among inline skate sports participants. The Newron inline skate seeks to foster the enjoyment of sports by people of all ages.

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Monday, May 10, 2010

TrustCash Management to Be Appointed as Director of Payment Processing of Alligato, Inc.

ATLANTA, GA--(Marketwire - 05/10/10) - TRUSTCASH HOLDINGS, INC. ("TRUSTCASH") (Pinksheets:TCHH - News) today confirms Kent Carasquero, the President of TrustCash, has agreed to serve as a Director of Payment Processing for Alligato, Inc.

The corporate vision of a combination of Alligato and TrustCash technology and expertise will continue to evolve. This appointment strengthens and confirms the relationship between the two companies.

ABOUT ALLIGATO

Alligato markets its service under the http://www.celllongdistance.com/ brand.

Alligato™ delivers the most sophisticated, comprehensive voice 2.0 platform available. The technology infrastructure provides the first truly open access to carrier-grade telecom functionality with hardware, software and network capacity to lower the cost of cell phone long distance from the wireless network to the Public Switched Telephone Network (PSTN) as an on-demand, fully hosted and managed service in a CaaS (Communications as a Service) model.

The Alligato service enables large member-based organizations, existing service providers, application providers and web communities to provide cell phone long distance for their customers and members with greater quality and at significantly lower costs (up to 90% savings).

Alligato currently offers its customers a postpaid billing model via credit card. Alligato management are excited to integrate TrustCash as an alternative, secure, private and reliable payment system which can be instrumental in the expanding distribution of their cell long distance service.

TAKE OUR ONLINE SURVEY

Tell us where you want to use TrustCash at:
http://www.trustcash.com/signup_consumer1.php.

ABOUT TRUSTCASH

The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.

The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.

Cautionary Statement Regarding Forward-Looking Statements
A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Sunday, May 9, 2010

Compassionate Therapeutic Solutions, LLC Opens Licensed Bakery to Produce Medical Marijuana Edibles

COLORADO SPRINGS, Colo., May 7, 2010 (GLOBE NEWSWIRE) -- GT Legend Automotive Holdings, Inc. (Pink Sheets:GTLA - News), in conjunction with Compassionate Therapeutic Solutions, LLC, has opened a fully-licensed bakery where edibles containing medical cannabis flowers will be produced. The bakery will distribute its edible organic products to the CTS center, and will act as a healthcare product provider to 200 plus medical centers in the state of Colorado.

According to Colorado state regulations, bakeries producing medical marijuana edibles must be licensed and must operate out of a state-regulated commercial kitchen. The CTS bakery has taken a leadership position in supplying product and meeting both requirements listed above. Patients who wish to purchase the edibles must be registered and in possession of a state-authorized medical marijuana permit card. The Denver Post reported that there are currently over 100,000 licensed medical marijuana users in the state of Colorado. The state of Colorado receives over 1,000 applications per day for authorized marijuana permit cards, yielding $90,000 per day in revenue from the registration fees (Source: Green Rights Radio 101.5, Denver).

Some patients prefer to consume edibles containing medical cannabis flowers as opposed to smoking the product because of health considerations. Many patients are not able to inhale smoke. Medical dosages are better controlled with edibles, teas and tinctures.

Eugene Espinosa, President of GTLA / CTS, states, "Our edibles are made from premium, organic medicinal cannabis flowers. Our plants are organically controlled; grown in a hydroponic green room free from pesticides and chemicals of any sort. They are provided with the proper nutrients, adequate light and temperature to insure the highest quality end result. We estimate that 1 out of 10 cardholders will prefer edibles over inhaled marijuana. Our goal is to create a market based on demand. We expect the edible market to exceed $60,000,000 annually in Colorado."

About Compassionate Therapeutic Solutions, LLC: Compassionate Therapeutic Solutions, LLC is a multidisciplinary behavioral health care practice that offers mental health, substance abuse and primary caregiver services to communities of Colorado. The company's focus is to provide cost-effective quality treatment and to create, promote, and maintain a positive customer relationship with clients, associates and the community. One of the functions of the clinic is to provide comprehensive care to individuals who are registered and authorized to utilize medical marijuana. Please visit our website at http://www.ctscare.org/ for more information.



Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

TCHH Comments on Upcoming Closing of Its Aligato Transaction and Its Opportunity in the E-Commerce Industry

E-Commerce Sales Expected to Grow to 189 Billion in 2012

ATLANTA, GA--(Marketwire - 05/07/10) - TRUSTCASH HOLDINGS, INC. ("TRUSTCASH" or the "COMPANY") (Pinksheets:TCHH - News) today announces it expects to close the acquisition of a minority stake of Aligato Inc. by Friday, May 14, 2010.

The Aligato transaction gives the Company a competitive advantage regarding its move into the mobile payments space, where it feels that most e-commerce will be transacted in the future.


•Previous Cisco IBSG E-commerce Surveys have noted that amongst other industry highlights:
•Mobile is a key growth channel http://newsroom.cisco.com/dlls/2008/ekits/Third_Annual_Cisco_IBSG_E_commerce_Survey.pdf and;
•E-commerce is still growing despite the economy. (http://www.cisco.com/web/about/ac79/docs/pov/Cisco_ECommerce_POV_0722_FINAL.pdf)

As the Internet continues to take an ever-greater market share of global retail revenues, the payments industry must continue to innovate and adapt to the evolving needs of both consumers and businesses.


•According to forecasts made by research firm eMarketer, US retail e-commerce sales will jump by 12.7 percent year-over-year during 2010 and reach USD 152.1 billion. 92 percent of those surveyed by the e-tailing group predicted their 2010 e-commerce revenues would climb from last year, with 33 percent of respondents projecting an increase between 6 percent and 15 percent.
•In 2010, the number of US customers who will research products online is projected to reach 162 million, with 82 percent of online researchers, accounting for 133 million people, turning into online shoppers. Sales in the online travel sector will grow by 4.6 percent annually and total USD 92.5 billion in 2010. Online retail and online travel will register USD 244.6 billion in 2010, growing at a 9 percent compound annual rate from 2009 to 2014, the same source indicates.
•eMarketer also states that in the next two years, e-commerce growth is expected to continue at the same pace, indicating that the economy is on its road to recovery. By 2012, e-commerce sales are to jump to USD 189.9 billion, up 11 percent year-over-year.

These statistics combined with the opportunities presented in the mobile commerce channel and recent major industry moves by the likes of Google investing in Corduro -- a mobile payments start up (http://techcrunch.com/2010/05/03/corduro-google-ventures/) further strengthen the TrustCash opportunity, vision and market position as a leading provider of alternative and adaptable payment solutions for both the web and mobile.

TAKE OUR ONLINE SURVEY

Tell us where you want to use TrustCash at:

http://www.trustcash.com/signup_consumer1.php.

ABOUT TRUSTCASH

The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.

The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Thursday, May 6, 2010

Compassionate Therapeutic Solutions, LLC Announces Profit Projections

COLORADO SPRINGS, Colo., May 6, 2010 (GLOBE NEWSWIRE) -- GT Legend Automotive Holdings, Inc. (Pink Sheets:GTLA - News) in conjunction with Compassionate Therapeutic Solutions, LLC, released a statement today discussing its profit projections.

The company has opened a licensed grow facility, thus reducing product costs and doubling profit margins. Now, instead of generating revenues of $75,000 per month, each location can bring in $150,000 per month, totaling $1,800,000 per year per center.

According to an article posted on CNBC.com, CNBC estimates that the marijuana industry is a $40 billion a year market (Source: http://classic.cnbc.com/id/36331495). The state of Colorado receives over 1,000 applications per day for authorized marijuana permit cards, yielding $90,000 per day in revenue from the registration fees (Source: Green Rights Radio 101.5, Denver).

Eugene Espinosa, President of GTLA, states, "Medical marijuana sells for around $420.00 per ounce, and the average patient's purchase is two ounces of product per month. Since we're utilizing our independent, licensed grow facility, we are able to increase our profit margin by approximately $100.00 per ounce of product, leading to amplified revenues."



About Compassionate Therapeutic Solutions, LLC: Compassionate Therapeutic Solutions, LLC is a multidisciplinary behavioral health care practice that offers mental health, substance abuse and primary caregiver services to communities of Colorado. The company's focus is to provide cost-effective quality treatment and to create, promote, and maintain a positive customer relationship with clients, associates and the community. One of the functions of the clinic is to provide comprehensive care to individuals who are registered and authorized to utilize medical marijuana. Please visit our website at www.ctscare.org for more information.


Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Wednesday, May 5, 2010

GTLA in Conjunction With Compassionate Therapeutic Solutions, LLC Gains Credibility Subsequent to the Passing of House Bill 1284

COLORADO SPRINGS, Colo., May 5, 2010 (GLOBE NEWSWIRE) -- GT Legend Automotive Holdings, Inc. (Pink Sheets:GTLA - News) in conjunction with Compassionate Therapeutic Solutions, LLC, reported today that on April 20, 2010, the Colorado House passed a medical marijuana bill (#1284) that placed strict regulations on the medical marijuana industry.

Under the bill, the Department of Public Health and Environment will promulgate new rules related to standards for issuing registry identification cards, documentation for physicians who prescribe medical marijuana, and sanctions for physicians who violate the bill. Compassionate Therapeutic Solutions is in compliance with all the regulations set forth in the bill, thereby increasing the center's credibility (Source: http://www.leg.state.co.us/CLICS/CLICS2010A/csl.nsf/fsbillcont3/0C6B6577EC6DB1E8872576A80029D7E2?Open&file=1284_ren.pdf).

CNBC estimates that the marijuana industry is a $40 billion a year market (Source: http://classic.cnbc.com/id/36331495). Medical marijuana is legal in 14 states: Colorado, California, Vermont, Washington, Alaska, Montana, Nevada, New Jersey, New Mexico, Oregon, Hawaii, Maine, Michigan and Rhode Island. Ballot measures or legislation allowing medical marijuana are pending in 14 additional states including Alabama, Delaware, Illinois, Iowa, Kansas, North Carolina, Pennsylvania, South Dakota, New York, Missouri, Maryland, Massachusetts, Tennessee and Wisconsin (Source: www.usatoday.com/money/industries/health/2010-04-20-medical-marijuana_N.htm). The state of Colorado receives over 1,000 applications per day for authorized marijuana permit cards, yielding $90,000 per day in revenue from the registration fees (Source: Green Rights Radio 101.5, Denver).

Eugene Espinosa, President of Compassionate Therapeutic Solutions, commented, "The Huffington Post stated in an article that reactions from the medical marijuana community were varied with regard to this bill. The Cannabis Therapy Institute called it a 'monstrosity,' while Sensible Colorado called it 'a step in the right direction.' We agree with the latter. We are an upstanding medical center staffed with licensed therapists and professionals who are prepared to offer the best possible care to our patients. While this bill may cause some centers to close, it will allow us to stay open due to our professional standing by licensure in the field." (Article Source: "Colorado Medical Marijuana Bill Passes House on 4/20, Moves to Senate for Approval", Posted 4/21/10, http://www.huffingtonpost.com/).

About Compassionate Therapeutic Solutions, LLC: Compassionate Therapeutic Solutions, LLC is a multidisciplinary behavioral health care practice that offers mental health, substance abuse and primary caregiver services to communities of Colorado. The company's focus is to provide cost-effective quality treatment and to create, promote, and maintain a positive customer relationship with clients, associates and the community. One of the functions of the clinic is to provide comprehensive care to individuals who are registered and authorized to utilize medical marijuana.


Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Tuesday, May 4, 2010

PMDP Technologies Can be Modified to Assist in Cleaning Oil Spills Such as the Current Spill in the Gulf of Mexico

WINSTON-SALEM, N.C., May 3, 2010 (GLOBE NEWSWIRE) -- Plateau Mineral Development, Inc. (Pink Sheets:PMDP - News) announced today that its partner company, Environmental Solutions (EnSol), has a technology that can be modified to assist in cleaning up oil spills such as the current one in the Gulf of Mexico. While the EnSol technology would require some modifications to meet the exact needs, those changes would be minor.

EnSol's technology can be used to reclaim the oil and tar, whilst restoring the beaches. It would take in a volume of contaminated sand, dissociate the components, extracting the oil and tar, thereby allowing clean sand to be deposited back onto the beach.

Robert Matthews of Plateau Mineral Development, Inc., states, "The oil spill in the Gulf of Mexico and its negative environmental impact is of significant importance at present. It is our goal to eventually use the green, environmentally-friendly EnSol technologies in an effort to help with the clean-up process of this any future oil spills."

About Plateau Mineral Development, Inc.: Plateau Mineral Development has been in existence for over five years.

Forward-Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Sunday, May 2, 2010

Compassionate Therapeutic Solutions, LLC Introduces the Wellness Center to Cancer Patients

COLORADO SPRINGS, Colo., April 30, 2010 (GLOBE NEWSWIRE) -- GT Legend Automotive Holdings, Inc. (Pink Sheets:GTLA - News) in conjunction with Compassionate Therapeutic Solutions, LLC, announced today that Eugene Espinosa, the company's President, has been busy promoting the CTS wellness center via a series of presentations to cancer patients in Colorado Springs and the surrounding communities.

The National Cancer Institute (NCI) is 1 of 27 Institutes and Centers that comprise the U.S. National Institutes of Health (NIH) and is a component of the U.S. Department of Health and Human Services. In the National Cancer Institute Act of 1937, NCI was established as the Nation's principal agency for cancer research. As a Federal Government agency, NCI receives its funds from the U.S. Congress. These funds support research at the Institute's headquarters in Bethesda, Maryland, and in laboratories and medical centers throughout the United States and in other countries. NCI's budget for the 2008 fiscal year was $4.83 billion. For the 2007 fiscal year, it was $4.79 billion, and, for 2006, it was $4.75 billion. (Source: http://www.cancer.gov/).

According to the American Cancer Society's 2003 data, more than 1,300,000 Americans are diagnosed with cancer each year. At least 300,000 of them will undergo chemotherapy, and 132,000 patients may have therapeutic cannabis recommended to them to combat the side effects of conventional treatments (Source: http://www.americansforsafeaccess.org/). Vinciguerra et al. found that 78% of 56 patients suffering from nausea who were resistant to standard drugs became symptom-free after inhaling cannabis (Source: http://www.concept420.com/).

A 1999 report published by the Institutes of Medicine stated that nausea, appetite loss, pain and anxiety, all of which are symptoms associated with cancer, can be mitigated by medical marijuana. The same report also stated that pills are generally ineffective in treating patients experiencing severe nausea or vomiting because of the difficulty in swallowing or keeping a pill down and the slow onset of the drug effect. Therefore, they conclude that cannabinoid inhalation is effective in treating the nausea that is caused by chemotherapy.

Kathryn Newman, R.N., M.S., states, "Medical marijuana can be used as a pain reliever to combat the discomfort caused by various cancers. It can also soothe the nausea associated with chemotherapy. In addition to pain relief, studies also show that the euphoric effects of the chemical THC which is contained in cannabis may act as a mood elevator; this is yet another benefit for cancer patients."



About Compassionate Therapeutic Solutions, LLC: Compassionate Therapeutic Solutions, LLC is a multidisciplinary behavioral health care practice that offers mental health, substance abuse and primary caregiver services to communities of Colorado. The company's focus is to provide cost-effective quality treatment and to create, promote, and maintain a positive customer relationship with clients, associates and the community. One of the functions of the clinic is to provide comprehensive care to individuals who are registered and authorized to utilize medical marijuana.



Forward Looking Statements:

This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Disclaimer

Average Joe's Picks is an independent electronic medium, which provides industry data and information on publicly traded companies for the use of our readers. Furthermore, the provided data should not be used as the sole basis for making any investment decision. The individual investor's own due diligence is of the utmost importance and highly recommended.